Literature DB >> 18338137

[Thrombelastometric detection of factor XIII deficiency].

C F Weber1, C Jambor, M Marquardt, K Görlinger, B Zwissler.   

Abstract

While undergoing Whipple's operation (pancreaticoduodenectomy) a patient developed diffuse bleeding and an unexpectedly high blood loss. An intraoperatively performed thrombelastometry with ROTEM (Pentapharm, Munich, Germany) showed an aprotonin-resistant mild fibrinolysis and suggested the presence of an isolated deficiency of coagulation factor XIII. This was confirmed by a second thrombelastometry, where no lysis was seen after in vitro substitution of factor XIII. After administration of 1250 IU factor XIII concentrate the diffuse bleeding ceased and further substitution of coagulation factor concentrates or fresh frozen plasma was not necessary. A postoperatively performed analysis confirmed the factor XIII deficiency (52%).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18338137     DOI: 10.1007/s00101-008-1360-8

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  15 in total

1.  Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency.

Authors:  W Lim; K Moffat; C P M Hayward
Journal:  J Thromb Haemost       Date:  2004-06       Impact factor: 5.824

2.  Preoperative fibrin monomer measurement allows risk stratification for high intraoperative blood loss in elective surgery.

Authors:  Wolfgang Korte; Konrad Gabi; Mirjam Rohner; Anita Gähler; Christine Szadkowski; Thomas W Schnider; Jochen Lange; Walter Riesen
Journal:  Thromb Haemost       Date:  2005-07       Impact factor: 5.249

3.  To bleed or not to bleed? Is that the question for the PTT?

Authors:  C S Kitchens
Journal:  J Thromb Haemost       Date:  2005-09-09       Impact factor: 5.824

Review 4.  [Coagulation management during liver transplantation].

Authors:  K Görlinger
Journal:  Hamostaseologie       Date:  2006-08       Impact factor: 1.778

5.  Characterization of an acquired IgG inhibitor of coagulation factor XIII in a patient with systemic lupus erythematosus.

Authors:  F Ahmad; S Solymoss; M C Poon; C Berube; A K Sullivan
Journal:  Br J Haematol       Date:  1996-06       Impact factor: 6.998

6.  Safety, pharmacokinetics, and immunogenicity of single-dose rFXIII administration to healthy volunteers.

Authors:  T C Reynolds; M D Butine; J E Visich; K A Gunewardena; M MacMahon; S Pederson; P D Bishop; K M Morton
Journal:  J Thromb Haemost       Date:  2005-05       Impact factor: 5.824

7.  Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures.

Authors:  R Gerlach; A Raabe; M Zimmermann; A Siegemund; V Seifert
Journal:  Surg Neurol       Date:  2000-09

Review 8.  Factor XIII deficiency: pathogenic mechanisms and clinical significance.

Authors:  R Egbring; A Kröniger; R Seitz
Journal:  Semin Thromb Hemost       Date:  1996       Impact factor: 4.180

9.  A practical concept for preoperative management of patients with impaired primary hemostasis.

Authors:  Juergen Koscielny; Georg-Friedrich von Tempelhoff; Sabine Ziemer; Hartmut Radtke; Michael Schmutzler; Pranav Sinha; Abdulgabar Salama; Holger Kiesewetter; Reinhard Latza
Journal:  Clin Appl Thromb Hemost       Date:  2004-04       Impact factor: 2.389

10.  The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography.

Authors:  Vance G Nielsen; William Q Gurley; Thomas M Burch
Journal:  Anesth Analg       Date:  2004-07       Impact factor: 5.108

View more
  3 in total

Review 1.  [Modern coagulation management in bleeding trauma patients : Point-of-care guided administration of coagulation factor concentrates and hemostatic agents].

Authors:  Marc Maegele
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-08-28       Impact factor: 0.840

2.  Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy.

Authors:  Klaus Görlinger; Dietmar Fries; Daniel Dirkmann; Christian F Weber; Alexander A Hanke; Herbert Schöchl
Journal:  Transfus Med Hemother       Date:  2012-03-08       Impact factor: 3.747

3.  Synchronous duodenal neuroendocrine neoplasm and congenital factor XIII deficiency: case report and review of the literature.

Authors:  Lei Shen; Lu Kong; Qi Zhuo; Roberta Elisa Rossi; Renata D'Alpino Peixoto; Nikolaos Tsoukalas; Xiaomei Zhang; Xinye Jin
Journal:  Ann Transl Med       Date:  2022-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.